Mochida Pharmaceutical
Hitoshi Mizuno is an accomplished executive with extensive experience in the biotechnology and pharmaceutical industries. Currently serving as the Executive Managing Officer and Head of the Biomaterials Business Division at Mochida Pharmaceutical since February 2018, Mizuno previously held influential roles such as Chief Executive Officer at Olympus Biotech Corporation from November 2010 to May 2013 and Division Manager of the Biotech Division at Olympus Corporation for over two decades. Other notable positions include President of Olympus Terumo Biomaterials Corp. and Manager at FANUC LTD. Mizuno's educational background includes a Bachelor of Arts in Mechanical Engineering and a Master of Science in Precision Machinery and Electronics from Tokyo Institute of Technology, along with an MBA from Bond University.
This person is not in any teams
This person is not in any offices
Mochida Pharmaceutical
Mochida Pharmaceutical Co., Ltd. is a Japan-based company, principally engaged in the production and sale of drugs. The Pharmaceutical-related segment is engaged in the manufacture, purchase and sale of pharmaceutical products, the purchase and sale of raw materials, brokerage and management of real estate properties, the maintenance and management of buildings, the agency of personal affairs, accounting and purchasing businesses, damage insurance agency business, as well as the publishing of medicine-related books and the production of print. The Healthcare segment is involved in the manufacture, purchase and sale of quasi drugs and cosmetic products.